5BW-13506-59563

3 vaccinations 9 coded responses 29 check-ins 9 free-text entries 0 call cases

Sex: Male
Age at first dose: 61-65
ZIP prefix: 770 / TX
Registered: 2021-04-20

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline Vaccinations Free text MedDRA terms

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-29
Dose 1 — Pfizer-BioNTech
2021-04-19
Dose 2 — Pfizer-BioNTech
2021-04-20
Registered in v-safe
2021-04-20
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-04-21
Survey response — days 1–6 daily, dose 2
MedDRA: Lymph node pain — Feeling: Fair · Site: Pain

Free text: Tender axillary lymph nodes on side of injected shoulder.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-22
Survey response — days 1–6 daily, dose 2
MedDRA: Lymph node pain — Feeling: Good

Free text: (Second day of) sensitive axillary lymph nodes on side of injection.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-23
Survey response — days 1–6 daily, dose 2
MedDRA: Lymph node pain — Feeling: Good

Free text: (For the third consecutive day, and finally to a lesser extent,) tender axillary lymph nodes on injection side.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-24
Survey response — days 1–6 daily, dose 2
MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good

Free text: (Decreasingly) tender axillary lymph nodes on injection side.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-25
Survey response — days 1–6 daily, dose 2
MedDRA: Lymph node pain — Feeling: Good

Free text: (Continuing to decrease, but still noticeable:) Tender axillary lymph nodes on injection side.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-26
Survey response — day 7, dose 2
MedDRA: Lymphadenopathy — Feeling: Good

Free text: (To a still decreasing extent,) axillary lymph nodes more sensitive to pressure on injection side than opposite side.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-03
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-10
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-17
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-05-24
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-05-31
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-19
Survey response — 3 months, dose 2
MedDRA: Upper respiratory tract infection — Feeling: Good

Free text: Symptoms suspected of being an ordinary upper respiratory infection with no specific reason to believe related to either the vaccine or to COVID-19.

MedDRA releases: 2024-11 · check-in free text available
2021-10-18
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-12-21
Dose 3 — Pfizer-BioNTech
2021-12-22
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-12-23
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · Fever · Headache

Adult check-in
2021-12-24
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-12-25
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-12-26
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-12-27
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-12-28
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2022-01-07
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-01-11
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2022-01-18
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2022-01-25
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-02-01
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-03-22
Health check-in — 3 months, dose 3
Feeling: Fair

Adult check-in
2022-06-23
Survey response — 6 months, dose 3
MedDRA: Fatigue, Illness, Neck pain, Pyrexia, Respiratory symptom, SARS-CoV-2 test negative — Feeling: Good

Free text: Brief period of fever, tiredness, minor neck ache (either from the illness or from doing something unusual with my neck possibly inspired by the illness) and upper respiratory symptoms. Negative rapid COVID-19 antigen test during symptoms.

MedDRA releases: 2024-11 · check-in free text available
2022-12-21
Survey response — 12 months, dose 3
MedDRA: Injection site discomfort, Lethargy, Pyrexia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: (NOTE: Pfizer COVID-19 booster, and also influenza vaccine, yesterday.) Fever and lethargy, very mild discomfort at COVID-19 injection site.

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-29	Pfizer-BioNTech
2	2021-04-19	Pfizer-BioNTech
3	2021-12-21	Pfizer-BioNTech	No

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-21

Systemic reaction (other): Tender axillary lymph nodes on side of injected shoulder.

2021-04-22

Systemic reaction (other): (Second day of) sensitive axillary lymph nodes on side of injection.

2021-04-23

Systemic reaction (other): (For the third consecutive day, and finally to a lesser extent,) tender axillary lymph nodes on injection side.

2021-04-24

Systemic reaction (other): (Decreasingly) tender axillary lymph nodes on injection side.

2021-04-25

Systemic reaction (other): (Continuing to decrease, but still noticeable:) Tender axillary lymph nodes on injection side.

Release 8 — day 7, dose 2

2021-04-26

Systemic reaction (other): (To a still decreasing extent,) axillary lymph nodes more sensitive to pressure on injection side than opposite side.

Release 9 — 3 months, dose 2

2021-07-19

Symptoms: Symptoms suspected of being an ordinary upper respiratory infection with no specific reason to believe related to either the vaccine or to COVID-19.

Release 12 — 6 months, dose 3

2022-06-23

Symptoms: Brief period of fever, tiredness, minor neck ache (either from the illness or from doing something unusual with my neck possibly inspired by the illness) and upper respiratory symptoms. Negative rapid COVID-19 antigen test during symptoms.

Release 12 — 12 months, dose 3

2022-12-21

Symptoms: (NOTE: Pfizer COVID-19 booster, and also influenza vaccine, yesterday.) Fever and lethargy, very mild discomfort at COVID-19 injection site.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Fatigue	·	·	✓
SD	Illness	·	·	✓
SD	Injection site discomfort	·	·	✓
SD	Lethargy	·	·	✓
SD	Neck pain	·	·	✓
SD	Pyrexia	·	·	✓
SD	Respiratory symptom	·	·	✓
SD	SARS-CoV-2 test negative	·	·	✓
SD	Upper respiratory tract infection	·	·	✓
SRO	Lymph node pain	✓	✓	✓
SRO	Lymphadenopathy	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release